Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
193.80    1.20 (0.62%)
Bid:
193.60
Ask:
194.20
Spread: 0.60 (0.31%)
Market Cap: £517.60m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Director/PDMR Shareholding

8 Apr 2015 12:25

RNS Number : 6301J
Costain Group PLC
08 April 2015
 

 

Costain Group PLC("Costain" or "the Company")

 

Transactions in shares by Persons Discharging Managerial Responsibilities ("PDMRs")

This notification is made in accordance with DTR 3.1.4(1).

 

(a) Total Beneficial Holding of Shares

 

Costain Group PLC announces that, following the exercise of share awards granted under the Company's Deferred Share Bonus Plan as detailed in section (b) below, the following Directors hold the number of ordinary shares of 50 pence each in the share capital of the Company (the 'shares') as set out in the table below:

 

Name of Director

Total beneficial holding of shares held prior to the transaction detailed in the section below

Total beneficial holding of shares held following the transaction detailed in section below

Andrew Wyllie

340,000

350,000

Anthony Bickerstaff

186,691

192,826

 

(b) Deferred Share Bonus Plan

 

On 03 April 2013, awards were granted under the Costain Group PLC Deferred Share Bonus Plan ("the Plan") to certain Directors of the Company. The awards were granted under the Plan in the form of options with a nil exercise price over a fixed number of shares (the "Deferred Award") and options over a fixed value of shares (the "Combined Deferred Award") granted in combination with an HMRC approved market value option over a fixed number of shares (the "Option"), (together "the Awards"). No consideration was paid for the grant of the Awards.

 

The Awards became exercisable on 03 April 2015 for a period up until the tenth anniversary of grant.

On 03 April 2015 the following Directors exercised their options to acquire the number of ordinary shares of 50 pence each in the share capital of the Company as set out in the table below. As detailed below, these individuals sold a proportion of the resulting ordinary shares, including sufficient to satisfy the exercise price of £2.59 (in respect of the Option only) and their income tax and national insurance liability arising on the exercise, and retained the remaining shares. In addition, in accordance with the Rules of the Plan, dividend shares were awarded representing the value of dividends that would have been due on the vested Deferred Award shares during the period between 03 October 2013 and 03 April 2015.

Name of Director

Total number of shares acquired on exercise of the Awards* (including dividend shares)

Exercise Price relating to the Option only

Number of shares sold to satisfy Tax and National Insurance Liabilities

Number of

shares Sold

(after tax)

Number of

shares Retained

(after tax)

Price at which shares were sold

Andrew

Wyllie

52,062

£2.59

24,470

17,592

10,000

£3.15

Anthony Bickerstaff

34,258

£2.59

16,102

12,021

6,135

£3.15

* as adjusted following the Capital Raising in March 2014

 

 

The Company was informed of the above exercise of options on 03 April 2015 and the number of shares sold/retained following exercise on 08 April 2015.

 

08 April 2015

Enquiries:

Costain Group PLC Tel: 01628 842444Tracey Wood

Company Secretary

 

Instinctif Partners

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

 

 

 

 

 

      

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSDFFAFISEEL
Date   Source Headline
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSCostain returns to FTSE 250
25th Feb 20266:00 pmRNSAshtead Group
24th Feb 20263:59 pmRNSDirector Declaration
23rd Feb 20262:59 pmRNSHolding(s) in Company
20th Feb 20264:19 pmRNSHolding(s) in Company
18th Feb 20261:55 pmRNSHolding(s) in Company
9th Feb 20262:50 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.